Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$122.71 - $146.91 $365,921 - $438,085
-2,982 Reduced 14.73%
17,267 $2.46 Million
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $644,109 - $857,383
-6,308 Reduced 23.75%
20,249 $2.6 Million
Q4 2023

Jan 30, 2024

SELL
$87.78 - $105.45 $93,836 - $112,726
-1,069 Reduced 3.87%
26,557 $2.75 Million
Q3 2023

Oct 23, 2023

BUY
$90.94 - $199.54 $1.31 Million - $2.87 Million
14,360 Added 108.25%
27,626 $2.51 Million
Q2 2023

Jul 24, 2023

SELL
$155.98 - $172.65 $226,638 - $250,860
-1,453 Reduced 9.87%
13,266 $2.15 Million
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $287,839 - $346,129
-2,175 Reduced 12.87%
14,719 $2.34 Million
Q4 2022

Feb 10, 2023

SELL
$102.55 - $135.33 $115,778 - $152,787
-1,129 Reduced 6.26%
16,894 $2.29 Million
Q3 2022

Nov 09, 2022

BUY
$95.28 - $116.93 $154,734 - $189,894
1,624 Added 9.9%
18,023 $1.8 Million
Q2 2022

Aug 16, 2022

SELL
$103.24 - $121.81 $191,923 - $226,444
-1,859 Reduced 10.18%
16,399 $1.83 Million
Q1 2022

May 13, 2022

BUY
$93.1 - $112.54 $631,776 - $763,696
6,786 Added 59.15%
18,258 $2.03 Million
Q4 2021

Feb 15, 2022

BUY
$95.88 - $117.08 $203,169 - $248,092
2,119 Added 22.66%
11,472 $1.29 Million
Q3 2021

Nov 09, 2021

BUY
$84.42 - $106.62 $113,882 - $143,830
1,349 Added 16.85%
9,353 $898,000
Q2 2021

Aug 13, 2021

SELL
$67.66 - $84.76 $359,477 - $450,329
-5,313 Reduced 39.9%
8,004 $671,000
Q1 2021

May 11, 2021

BUY
$67.06 - $75.82 $203,929 - $230,568
3,041 Added 29.59%
13,317 $898,000
Q4 2020

Feb 10, 2021

BUY
$63.89 - $73.8 $198,570 - $229,370
3,108 Added 43.36%
10,276 $718,000
Q3 2020

Nov 10, 2020

BUY
$63.69 - $70.22 $200,941 - $221,544
3,155 Added 78.62%
7,168 $498,000
Q2 2020

Aug 05, 2020

BUY
$58.54 - $67.94 $234,921 - $272,643
4,013 New
4,013 $263,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Svb Wealth LLC Portfolio

Follow Svb Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.